Phase II study of ifosfamide and cisplatin for the treatment of recurrent ovarian cancer. [electronic resource]
Producer: 20131023Description: 653-60 p. digitalISSN:- 1432-0843
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carcinoma, Ovarian Epithelial
- Cisplatin -- administration & dosage
- Disease Progression
- Drug Resistance, Neoplasm
- Female
- Humans
- Ifosfamide -- administration & dosage
- Middle Aged
- Neoplasm Recurrence, Local
- Neoplasms, Glandular and Epithelial -- drug therapy
- Ovarian Neoplasms -- drug therapy
- Survival Rate
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.